Nothing Special   »   [go: up one dir, main page]

Yap, 1993 - Google Patents

Humoral Functions of Immunoglobulin: Relationship to Purification Technology of Intravenous Immunoglobulin

Yap, 1993

Document ID
14642729223172381609
Author
Yap P
Publication year
Publication venue
Immunology and Blood Transfusion: Proceedings of the Seventeenth International Symposium on Blood Transfusion, Groningen 1992, organized by the Red Cross Blood Bank Groningen-Drenthe

External Links

Snippet

One of the major therapeutic achievements in the field of clinical immunology in the last twenty years has been the development of safe and effective immunoglobulin of therapeutic applications in immunodeficiency, autoimmune disease and infectious diseases [1-3] …
Continue reading at link.springer.com (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen

Similar Documents

Publication Publication Date Title
EP1084147B1 (en) Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
EP0073371B1 (en) Intravenously injectable immune serum globulin and method of preparing same
DK2270044T3 (en) Liquid immunoglobulin G (IgG) product
CA1208555A (en) Composition having enhanced opsonic activity
KR100368563B1 (en) Preparation method of anti-D immunoglobulin G concentrate and pharmaceutical preparation containing the same
EP0269405B1 (en) Pasteurization of immunoglobulin solutions
WO2005072772A1 (en) Pharmaceutical compositions
US7597891B2 (en) Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases
US20080145370A1 (en) SYNTHESIS OF HUMAN SECRETORY IgM AND THE TREATMENT OF COLSTRIDIUM DIFFICILE ASSOCIATED DISEASES HEREWITH
Dwyer Thirty years of supplying the missing link: History of gamma globulin therapy for immunodeficient states
Stiehm et al. Preparation and use of therapeutic antibodies primarily of human origin
Hässig Intravenous immunoglobulins: pharmacological aspects and therapeutic use
Boshkov et al. Use of intravenous gammaglobulin as an immune replacement and an immune suppressant
JPH0365327B2 (en)
Schiff Intravenous gammaglobulin: pharmacology, clinical uses and mechanisms of action.
Schwartz Overview of the biochemistry and safety of a new native intravenous gamma globulin, IGIV, pH 4.25
Fischer Therapeutic uses of intravenous gammaglobulin for pediatric infections
Yap Humoral Functions of Immunoglobulin: Relationship to Purification Technology of Intravenous Immunoglobulin
EP0973549A2 (en) Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties
Hammarström et al. The use of intravenous IgG as prophylaxis and for treatment of infections
FISCHER Immunoglobulin therapy of neonatal group B streptococcal infections: an overview
Amber et al. Role of intravenous immunoglobulin in dermatologic disorders
Ramesh et al. Therapeutic uses of intravenous immunoglobulin (IVIG) in children
Schwartz Immunoglobulin metabolism
Price et al. Hyperimmune immunoglobulin G